Clinical Trial Update: Advanced GC Multi-omic Characterization in EU and CELAC Populations

View source ↗

Summary

Clinical trial NCT04015466 reports a completed multi-omic characterization study of gastric cancer in EU and CELAC populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Gastric Cancer | Status: COMPLETED